#ECTRIMS2016 – This Year’s Interesting Topics
The countdown is on to ECTRIMS 2016 where myriad interesting topics associated with multiple sclerosis will take center stage.
This year, Multiple Sclerosis News Today will offer daily follow-up coverage of the 2016 annual European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress to be held Sept. 14 – 17, in London.
For now, we’ve posted a few congress topics and some MS related news stories for you to catch up on.
1. The role of B cells in MS
The role of B cells in MS will be a hot topic this year. Researchers will be explaining their studies and looking into the future of B cells. S. Hauser, from San Francisco, will present “Clinical trials and role of B-cell depletion therapy in relapsing-remitting MS.”
2. Physical activity and rehabilitation
Exercise and rehabilitation will always be an important subject when it comes to MS, this year will be no exception. F. Boesen from Haslev, Denmark, will present “Effects on health-related quality of life from multidisciplinary rehabilitation in multiple sclerosis: a randomized controlled trial — the Danish MS hospitals rehabilitation study.”
3. MS care (optimization)
Patient care is ever-evolving, and there will be workshops and presentations explaining how this area can be improved upon. G. Edan, Rennes, France, will present “The initial treatment of early active relapsing-remitting MS should be with a potent induction therapy rather standard immunomodulation then escalation.”
4. Bone marrow transplants and stem cell therapy
Stem cell therapy is big news in many chronic illnesses, and the congress is likely to focus on the subject heavily. G.L. Mancardi from Genoa, Italy, will present “Bone marrow transplantation is a justifiable treatment for active relapsing multiple sclerosis.”
Presentations will include findings from studies into promoting remyelination. C. Lubetzki, Paris, France, will lead the teaching course “Models of myelination and remyelination to identify potential therapeutic cues.”
An ever-changing field, imaging is a fast moving science — improvement can only help advance the diagnosis process for MS patients. B. Stankoff, Paris, France, will present “PET imaging of cellular and molecular abnormalities in MS.”
7. MS registries
Sharing big data can help in improving prognosis for MS patients.
8. Gut microbiota
Gut microbiota is increasingly being seen an important environmental risk factor for multiple sclerosis.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.